Depression and smoking cessation: Does the evidence support psychiatric practice?

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 4, 2007, Pages 487-493

  Lembke, Anna ^a   Johnson, Kenasha ^a   DeBattista, Charles ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Depression; Nicotine dependence; Psychiatry; Smoking cessation; Withdrawal

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NICOTINE; NICOTINE PATCH; NON PRESCRIPTION DRUG; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VARENICLINE;

CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; INHALER; LOZENGE; MAJOR DEPRESSION; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; RECOMMENDED DRUG DOSE; REVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT;

EID: 35649001454     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Ahluwalia JS, Harris KJ, Catley D, et al. 2002. Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. JAMA, 288:468-74.
2. Anda RF, Williamson DF, Escobedo LG, et al. 1990. Depression and the dynamics of smoking. A national perspective. JAMA, 264:1541-45.
3. [APA] American Psychiatric Association. 1996. Practice guideline for the treatment of patients with nicotine dependence. American Journal of Psychiatry, 151:1-31.
4. Bergen AW, Caporaso N. 1999. Cigarette smoking. J Natl Cancer Inst, 91:1365-75.
5. Brown RA, Kahler CW, Niaura R, et al. 2001. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol, 69:471-80.
6. Burgess ES, Brown RA, Kahler CW, et al. 2002. Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol, 70:356-61.
7. Catley D, Harris KJ, Okuyemi KS, et al. 2005. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res, 7:859-70.
8. Cinciripini PM, Wetter DW, Fouladi RT, et al. 2003. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol, 71:292-301.
9. Covey LS, Glassman AH, Stetner F. 1997. Major depression following smoking cessation. Am J Psychiatry, 154:263-65.
10. Covey LS, Glassman AH, Stetner F, et al. 2002. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry, 159:1731-37.
11. Cox LS, Patten CA, Niaura RS, et al. 2004. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med, 19:828-34.
12. Farrell M, Howes S, Bebbington P, et al. 2001. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry, 179:432-37.
13. Glassman AH, Covey LS, Stetner F, et al. 2001. Smoking cessation and the course of major depression: a follow-up study. Lancet, 357:1929-32.
14. Glassman AH, Helzer JE, Covey LS, et al. 1990. Smoking, smoking cessation, and major depression. JAMA, 264:1546-49.
15. Gonzales D, Rennard SI, Nides M, et al. 2006. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA, 296:47-55.
16. Haas AL, Munoz RF, Humfleet GL, et al. 2004. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol, 72:563-70.
17. Hall RG, Duhamel M, McClanahan R, et al. 1995. Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J Nerv Ment Dis, 183:468-71.
18. Hall SM, Humfleet GL, Reus VI, et al. 2002. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry, 59:930-36.
19. Hall SM, Reus VI, Munoz RF, et al. 1998. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry, 55:683-90.
20. Haug NA, Hall SM, Prochaska JJ, et al. 2005. Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine Tob Res, 7:217-24.
21. Henningfield JE, Fant RV, Buchhalter AR, et al. 2005. Pharmacotherapy for nicotine dependence. CA Cancer J Clin, 55:281-299; quiz 322-283, 25.
22. Himelhoch S, Daumit G. 2003. To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry, 160:2228-30.
23. Hitsman B, Borrelli B, McChargue DE, et al. 2003. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol, 71:657-63.
24. Hughes J, Stead L, Lancaster T. 2004. Antidepressants for smoking cessation. Cochrane Database Syst Rev, CDO00031.
25. Hurt RD, Sachs DP, Glover ED, et al. 1997. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med, 337:1195-202.
26. Jack LM, Swan GE, Thompson E, et al. 2003. Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting. Prev Med, 36:585-93.
27. John U, Meyer C, Rumpf HJ, et al. 2004. Depressive disorders are related to nicotine dependence in the population but do not necessarily hamper smoking cessation. J Clin Psychiatry, 65:169-76.
28. Jorenby DE, Hays JT, Rigotti NA, et al. 2006. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA, 296:56-63.
29. Jorenby DE, Leischow SJ, Nides MA, et al. 1999. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med, 340:685-91.
30. Kahler CW, Brown RA, Ramsey SE, et al. 2002. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol, 111:670-75.
31. Killen JD, Fortmann SP, Kraemer HC, et al. 1996. Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. J Consult Clin Psychol, 64:1060-67.
32. Kotlyar M, Hatsukami DK. 2002. Managing nicotine addiction. J Dent Educ, 66:1061-73.
33. Lerman C, Niaura R, Collins BN, et al. 2004. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav, 18:362-66.
34. Levine MD, Marcus MD, Perkins KA. 2003. A history of depression and smoking cessation outcomes among women concerned about post-cessation weight gain. Nicotine Tob Res, 5:69-76.
35. Malone KM, Waternaux C, Haas GL, et al. 2003. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry, 160:773-79.
36. Martini S, Wagner FA, Anthony JC. 2002. The association of tobacco smoking and depression in adolescence: evidence from the United States. Subst Use Misuse, 37:1853-67.
37. Maurice ETA, Merritt It, Caraballo R, et al. 2005. Cigarette smoking among adults - United States 2004. MMWR Weekly, 54:1121-24.
38. Niaura R, Spring B, Borrelli B, et al. 2002. Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol, 70:887-896.
39. Plante GE. 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism, 54:45-48.
40. Pomerleau OF, Pomerleau CS, Mehringer AM, et al. 2005. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob Res, 7:91-102.
41. Prochaska JJ, Rossi JS, Redding CA, et al. 2004. Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend, 76:143-51.
42. Prochazka AV, Weaver MJ, Keller RT, et al. 1998. A randomized trial of nortriptyline for smoking cessation. Arch Intern Med, 158:2035-39.
43. Richmond R, Zwar N. 2003. Review of bupropion for smoking cessation. Drug Alcohol Rev, 22:203-220.
44. Shytle RD, Silver AA, Lukas RJ, et al. 2002. Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry, 7:525-35.
45. Sweeney CT, Fant RV, Fagerstrom KO, et al. 2001. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs, 15:453-67.
46. Thorsteinsson HS, Gillin JC, Patten CA, et al. 2001. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology, 24:350-58.